Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update - Marketscreener.com
| BIEL Stock | USD 0.0003 0.0001 50.00% |
About 51% of Bioelectronics Corp's institutional investors are presently thinking to get in. The analysis of overall sentiment of trading Bioelectronics Corp pink sheet suggests that some investors are interested at this time. Bioelectronics Corp's investing sentiment shows overall attitude of investors towards Bioelectronics Corp.
Bioelectronics Corp pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Bioelectronics daily returns and investor perception about the current price of Bioelectronics Corp as well as its diversification or hedging effects on your existing portfolios.
Bioelectronics |
Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update Marketscreener.com
Read at news.google.com
 |
Bioelectronics Corp Fundamental Analysis
We analyze Bioelectronics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioelectronics Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioelectronics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Z Score
Z Score Comparative Analysis
Bioelectronics Corp is currently under evaluation in z score category among its peers. Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Peers
Trending Equities
Other Information on Investing in Bioelectronics Pink Sheet
Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.